For Novo Nordisk, the bid represents the most daring, and bold, venture so far under new CEO Maziar Mike Doustdar. Credit: PJ ...

Eli Lilly will invest over $1.2bn into its manufacturing site in Puerto Rico, as it aims to assemble a robust supply chain ...

Two of the world’s largest pharmaceutical companies, Pfizer (New York, US) and Roche (Basel, Switzerland), have unveiled more ...

Seres is set to receive up to $3.6m in further non-dilutive funding from the international non-profit partnership, CARB-X.

Dewpoint Therapeutics has received the US FDA's ODD for DPTX3186, a small-molecule condensate modulator for treating gastric ...

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

Elevara’s first-in-class asset ERV001, a CDK4/6 inhibitor, is set to enter Phase II testing as an add-on treatment in RA.

European biotechs should leverage its innovation and collaborate with Asian manufacturing hubs to secure greater investment, ...

GSK now owns the global development and commercialisation rights to Empirico's COPD-targeting (siRNA) oligonucleotide, ...

Regeneron is planning to re-apply to the FDA with a new pre-filled syringe manufacturing filler in January 2026.

Lifecore Biomedical and PolyPeptide Laboratories have linked to deliver an end-to-end peptide manufacturing solution for US ...

A sales probe from Organon's board has found evidence of wholesaler sales malpractice, resulting in Ali's resignation and a ...